Financiere de Tubize SA operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Financiere de Tubize SA with three other
pharmaceutical manufacturers in Europe:
sales of 126.20 million Euros [US$142.59 million]
of which 103%
was Commercialized Vaccines),
of UNITED KINGDOM
(£259.90 million [US$328.16 million]
of which 100%
was Sales of antibodies and related products), and
Laboratorios Farmaceuticos Rovi S.A.
based in SPAIN
(381.31 million Euros [US$430.86 million]
of which 83%
Financiere de Tubize SA reported sales of 286.08 million Euro (US$323.25 million)
December of 2019.
decrease of 0.8%
versus 2018, when the company's sales were 288.25 million Euro.